Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vietnam Report Says Need For Bulk Drugs Imports Reflects Hi-Tech Lack

This article was originally published in PharmAsia News

Executive Summary

The Drug Administration of Vietnam says local drug production meets only about half of the nation's demand, and even that amount relies mostly on imported bulk drugs. The board chairman of Vietnam Medical Products Import-Export said the cause is a lack of adequate investment in the technologies necessary to exploit medicinal plants. The Vietnamese drug industry lacks the large high-tech extraction plants necessary to end its reliance on bulk imports from China and other countries, the chairman alleged. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts